🇺🇸 FDA
Patent

US 9962366

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

granted A61KA61K31/00A61K31/122

Quick answer

US patent 9962366 (Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof) held by Amazentis SA expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/00, A61K31/122, A61K31/198, A61K31/205